Production

  1. Bioburden And EU GMP Annex 1: Risk Assessment, Reduction, And Testing

    Experts on regulation, filtration, sampling, and quality control discuss risk assessment and filtration-based strategies to reduce bioburden.

  2. How To Plan For Trouble-Free Filter Validation 10/28/2024

    Watch to learn when filter validation should be performed, what is required from an end user and laboratory testing perspective, and how to achieve first-time success for various drug products.

  3. Intensification Strategies For Upstream, Downstream Processes 3/8/2022

    How do you know if an intensification approach will provide advantages? Three process intensification experts show how various intensification approaches affect outputs using different scenarios.

  4. Thermo Fisher Scientific China Single-Use Technologies Capacity Expansion 3/2/2021

    Thermo Fisher Scientific is expanding our single-use manufacturing network globally. With continuous growth in China’s population, we have seen an increase in demand for human therapeutics and vaccines and an even greater need for investment in public health and safety to develop biopharmaceutical products in China.

  5. Slurry Bin Functionality With The DAC Ergo 3/22/2023

    Check out how our optional stainless-steel bin works in conjunction with the DAC Ergo to capture spent media.

  6. Singapore Single-Use Site Capacity Expansion 6/1/2022

    Thermo Fisher Scientific is expanding our single-use manufacturing network globally, an expansion site closer to Asia Pacific region

  7. Challenges Of The IVT Reaction In mRNA Production 2/24/2023

    mRNA synthesizes from the plasma template in the in vitro transcription (IVT) step. Learn tips from a principal scientist for optimizing the IVT step of mRNA production and purification.

  8. Your Contract Manufacturer Partner 12/14/2020

    Discover an integrated solution for pharmaceutical companies that offers a broad range of manufacturing services and capabilities to produce high-quality devices.

  9. Accelerating Progress: Key Considerations For CDMOs To Maximize Productivity And Scalability 6/29/2021

    Due to the urgent demand for vaccines and treatments, the biopharmaceutical industry is experiencing disruptive changes and increased demand on resources that are requiring a significant operational transformation. To accelerate the delivery of life-saving therapeutics, it is essential to evaluate effective ways to maximize efficiencies and increase capacity while minimizing risk. Flexibility is critical in bioprocessing today to stay up to speed with the quickly shifting needs of the industry.

  10. A Conceptual Overview Of The BioSMB MCC Platform 6/7/2021

    In this video, our technology expert Jason Forte describes how the BioSMB system offers 3-5 fold increase in productivity, yielding up to 80% savings on chromatography resin costs with minimal disruption to the accepted ways of doing chromatography today.